Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:2301-2306

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thome, L. M.
Right arrow Articles by Sarembock, I. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thome, L. M.
Right arrow Articles by Sarembock, I. J.

(Circulation. 1998;98:2301-2306.)
© 1998 American Heart Association, Inc.


Basic Science Reports

Early Plus Delayed Hirudin Reduces Restenosis in the Atherosclerotic Rabbit More Than Early Administration Alone

Potential Implications for Dosing of Antithrombin Agents

Leonard M. Thome, MD; Lawrence W. Gimple, MD; Brian G. Bachhuber, MD; Coleen A. McNamara, MD; Michael Ragosta, MD; S. David Gertz, MD, PhD; Eric R. Powers, MD; Gary K. Owens, PhD; John E. Humphries, MD; ; Ian J. Sarembock, MB, ChB, MD

From the Cardiovascular Division and the Department of Molecular Physiology and Cellular Biophysics (G.K.O.), Department of Medicine, University of Virginia, Charlottesville, and the Department of Anatomy and Cell Biology, Hadassah Medical School, Jerusalem, Israel (S.D.G.).

Correspondence to Ian J. Sarembock, MD, Health Sciences Center, Box 158, Charlottesville, VA 22908. E-mail isarembock{at}virginia.edu

Background—A 2-hour infusion of r-hirudin at the time of balloon angioplasty limits restenosis in atherosclerotic rabbits. Because thrombin activity in the vessel wall after angioplasty remains high for 48 to 72 hours, we hypothesized that a second infusion of hirudin at 24 hours would reduce restenosis more than early treatment alone.

Methods and Results—Femoral atherosclerosis was induced in 35 rabbits by air desiccation injury and a high-cholesterol diet. At the time of angioplasty, rabbits were randomly assigned to 1 of 4 groups: controls: heparin bolus, saline infusion at 24 hours; early hirudin: hirudin bolus+2 hours' infusion, saline infusion at 24 hours; delayed hirudin: heparin bolus, hirudin infusion±bolus at 24 hours; and early+delayed hirudin: hirudin bolus+2 hours' infusion, hirudin infusion±bolus at 24 hours. Rabbits were euthanized after 28 days. The early+delayed hirudin treatment group had less loss of minimal lumen diameter by angiography at 28 days. By histomorphometry, cross-sectional area narrowing by plaque was least in the early+delayed treatment group compared with controls (P=0.0001), early hirudin (P=0.01), or delayed hirudin (P=0.001). The early+delayed hirudin group also had a significant reduction in absolute plaque area and an improvement in lumen area compared with the other groups. No differences were observed between treatment groups with respect to the cross-sectional area encompassed by the internal or external elastic laminae.

Conclusions—Combined early+delayed administration of hirudin significantly reduces angiographic restenosis and cross-sectional area narrowing by plaque compared with early or late treatment alone. These results suggest that restenosis after balloon angioplasty is markedly influenced by thrombin-mediated events not only occurring early but also extending beyond the first 24 hours in this model.


Key Words: restenosis • atherosclerosis • hirudin




This article has been cited by other articles:


Home page
Circ. Res.Home page
J. Kim, L. Zhang, K. Peppel, J.-H. Wu, D. A. Zidar, L. Brian, S. M. DeWire, S. T. Exum, R. J. Lefkowitz, and N. J. Freedman
{beta}-Arrestins Regulate Atherosclerosis and Neointimal Hyperplasia by Controlling Smooth Muscle Cell Proliferation and Migration
Circ. Res., July 3, 2008; 103(1): 70 - 79.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. H. Mnjoyan, D. Doan, J. L. Brandon, K. Felix, C. L. Sitter, A. A. Rege, T. A. Brock, and K. Fujise
The critical role of the intrinsic VSMC proliferation and death programs in injury-induced neointimal hyperplasia
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2276 - H2284.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Kalinowski, H. Alfke, S. Bergen, K. J. Klose, J. J. Barry, and H.-J. Wagner
Comparative Trial of Local Pharmacotherapy with L-Arginine, r-Hirudin, and Molsidomine to Reduce Restenosis after Balloon Angioplasty of Stenotic Rabbit Iliac Arteries
Radiology, June 1, 2001; 219(3): 716 - 723.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Patterson, G. A. Stouffer, N. Madamanchi, and M. S. Runge
New Tricks for Old Dogs : Nonthrombotic Effects of Thrombin in Vessel Wall Biology
Circ. Res., May 25, 2001; 88(10): 987 - 997.
[Abstract] [Full Text] [PDF]